Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus

Transplantation

Volumn 83, Issue 3, 2007, Pages 277-281

  Hricik, Donald E ^a,b   Augustine, Joshua J ^a,b   Knauss, Thomas C ^a,b   Bodziak, Kenneth A ^a,b   Aeder, Mark ^a,b   Siegel, Christopher ^a,b   Schulak, James A ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

African American; Kidney transplantation; Steroid withdrawal

Indexed keywords

CORTICOSTEROID; CREATININE; METHYLPREDNISOLONE; PREDNISONE; RAPAMYCIN; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LUNG TUBERCULOSIS; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; STEROID THERAPY; TREATMENT OUTCOME;

ADULT; AFRICAN AMERICANS; CREATININE; DRUG THERAPY, COMBINATION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; SIROLIMUS; STEROIDS; TACROLIMUS; TREATMENT OUTCOME;

EID: 33846963136     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000251652.42434.57     Document Type: Article

References (20)

1. Hricik DE. Steroid-free immunosuppression in kidney transplantation: An editorial review. Am J Transplant 2002; 2: 19.
2. Hricik DE, Whalen C, Lautman J, et al. Withdrawal of steroids after renal transplantation: Clinical predictors of outcome. Transplantation 1992; 53: 41.
3. Ahsan N, Hricik D, Matas A, et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Transplantation 1999; 68: 186.
4. Boardman RE, Alloway RR, Alexander JW, et al. African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am J Transplant 2005; 5: 356.
5. Kumar MSA, Moritz MJ, Saaed MI, et al. Avoidance of chronic steroid therapy in African American kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant 2005; 5: 1976.
6. Hricik DE, Knauss TC, Bodziak KA, et al. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2003; 76: 938.
7. Kandaswamy R, Melancon JK, Dunn TY, et al. A prospective randomized trial of steroid-free maintenance regimens in kidney transplant recipients - an interim analysis. Am J Transplant 2005; 5: 1529.
8. Matas AJ, Kandaswamy R, Humar A, et al. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg 2004; 240: 510.
9. Sinclair NR, Canadian Multicenter Transplant Study Group. Low dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992; 147: 645.
10. Tarantino A, Montagnino G, Ponticelli C. Corticosteroids in kidney transplant recipients: safety issues and timing of discontinuation. Drug Saf 1995; 13: 145.
11. Hollander AMJ, Hene RJ, Hermans J, et al. Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study. J Am Soc Nephrol 1997; 8: 294.
12. Ratcliffe PJ, Dudley CRK, Higgins RM, et al. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 348: 643.
13. Koyama H, Cecka JM, Terasaki PI. Kidney transplant in black recipients; HLA matching and other factors affecting long-term graft survival. Transplantation 1994; 57: 1064.
14. Isaacs RB, Nock SL, Spencer CE, et al. Racial disparities in renal transplant outcomes. Am J Kidney Dis 1999; 34: 706.
15. Kerman RH, Kimball PM, Van Buren CT, et al. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation 1991; 51: 338.
16. Hutchings A, Purcell WM, Benfield MR. Increased costimulatory responses in African-American kidney allograft recipients. Transplantation 2001; 71: 692.
17. Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomized multicenter study. The Rapamune Study Group. Lancet 2000; 356: 194.
18. MacDonald AS. A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts. Transplantation 2001; 71: 271.
19. Meier-Kriesch HU, Schold JD, Srinivas TR, et al. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005; 5: 2273.
20. Laftavi MR, Stephan R, Stefanick B, et al. Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery 2005; 137: 364.